THE Priceline Pharmacy network is a vital part of the Australian Pharmaceutical Industries strategy, with the company saying it will continue to capitalise on its strengths in the health and beauty retail market in the coming year.
According to the API annual report released late last week, the Board undertook a review of its short and long term strategies, including continued growth for Priceline which is seen as a "compelling proposition for pharmacists who wish to offset the impact of PBS reform, leverage business, pharmacy and retail expertise, and drive further growth from integrated dispensary and retail programs".
Other priorities going forward include executing the "Next Generation" Priceline store concept across the network and building engagement with the Priceline Sister Club loyalty program.
API also aims to grow its Soul Pattinson and Club Premium buying programs, expand its health & beauty retail brand portfolio, and "optimise the value of the business portfolio through investment, divestment and acquisition".
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Dec 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Dec 16
